Raytheon, a unit of RTX (NYSE: RTX), has landed a multi-year AMRAAM missile production contract worth up to $20.7 billion from the federal government.
The agreement is tied directly to the Department of War’s Arsenal of Freedom initiative, which is designed to accelerate delivery of advanced air-to-air missile systems.
The multi-year award is structured to expand AMRAAM manufacturing capacity in order to meet large-scale government demand for missile systems.
RTX currently operates as a $252.9 billion aerospace and defense contractor supplying systems and services to military, commercial, and government customers worldwide.
A long-term AMRAAM production agreement fits squarely into RTX’s core role as a key weapons supplier for major US defense programs.
The contract plugs directly into the RTX narrative that hinges on converting a $289 billion backlog, especially long-duration munitions deals, into tangible revenue and operating profit.
A potential $20.7 billion framework for a single missile family reinforces the catalyst around higher-volume, multi-year agreements that investors have been tracking closely.
The Arsenal of Freedom scope aligns with earlier commentary on contracts where missile volumes are expected to rise between 2x and 4x, a significant production ramp-up.
For investors holding RTX, the contract strengthens the case that Raytheon’s order book is not just large but increasingly locked into structured, long-term production plans.
The critical proof point remains whether RTX can actually get AMRAAM output to the levels implied by this deal while preserving margins across the production timeline.
Analysts and investors will want to watch reported book-to-bill figures in the Raytheon segment, along with missile shipment volumes tied specifically to the Arsenal of Freedom initiative.
Management’s updates on missile capacity within the planned $10 billion to $10.5 billion 2026 capital program will also serve as a key indicator of whether backlog is converting at the assumed pace.
RTX shares were down 0.69% at the time this contract was reported, though the long-term implications of a deal this size are widely viewed as a meaningful positive for the company’s munitions business.
